openPR Logo
Press release

Skin Burns Market to Witness Growth During the Forecast Period (2023-32), Estimates DelveInsight | Key Companies - Global Blood Therapeutics, GlycoMimetics, Asklepion Pharmaceutical

07-07-2023 05:24 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Skin Burns Market

Skin Burns Market

(Las Vegas, Nevada, United States), DelveInsight's "Skin Burns Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Skin Burns, historical and forecasted epidemiology as well as the Skin Burns market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Skin Burns Overview
A burn is an injury to the skin or other organic tissue primarily caused by heat or due to radiation, radioactivity, electricity, friction or contact with chemicals. Thermal (heat) burns occur when some or all of the cells in the skin or other tissues are destroyed by: hot liquids (scalds).
Burns are classified by degree depending on how deeply and severely they penetrate the skin's surface: first, second, third, or fourth. It may be impossible to classify a burn immediately when it occurs. It can progress over time so you may not know the full extent for a day or two.
First-degree (superficial) burns. First-degree burns affect only the outer layer of skin, the epidermis. The burn site is red, painful, dry, and has no blisters. Mild sunburn is an example. Long-term tissue damage is rare and often consists of an increase or decrease in skin color.
Second-degree (partial thickness) burns. Second-degree burns involve the epidermis and part of the lower layer of skin, the dermis. The burn site looks red, blistered, and may be swollen and painful.
Third-degree (full thickness) burns. Third-degree burns destroy the epidermis and dermis. They may go into the innermost layer of skin, the subcutaneous tissue. The burn site may look white or blackened and charred.
Fourth-degree burns. Fourth-degree burns go through both layers of the skin and underlying tissue as well as deeper tissue, possibly involving muscle and bone. There is no feeling in the area since the nerve endings are destroyed.

Skin Burns Epidemiological Insights
Leg ulcers usually occur secondary to venous reflux or obstruction, but 20% of people with leg ulcers have arterial disease, with or without venous disorders. Between 1.5 and 3.0 in 1000 people have active leg ulcers. Prevalence increases with age to about 20 in 1000 people aged over 80 years

Leading Companies Working in the Skin Burns Market
Navitor Pharmaceuticals
Supernus Pharmaceuti
Novartis
Relmada Therapeutics
And many others

Promising Therapies in the Skin Burns Market
SPRAVATO
MIJ821
COMP360
Psilocybin
And many others
Learn more about the Skin Burns key companies and emerging therapies @ Skin Burns Therapeutics Market Analysis

Scope of the Skin Burns Market Report
Study Period: 2019-2032
Coverage: 7MM [The United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, Japan]
Key Skin Burns Companies: Navitor Pharmaceuticals, Supernus Pharmaceuti, Novartis, Relmada Therapeutics and many others
Key Skin Burns Therapies: SPRAVATO, MIJ821, COMP360, Psilocybin and many others
Therapeutic Assessment: Skin Burns current marketed and emerging therapies
Skin Burns Market Dynamics: Skin Burns market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL's views, Analyst's views, Skin Burns Market Access and Reimbursement

Table of Contents
1. Skin Burns Market Key Insights
2. Skin Burns Market Report Introduction
3. Skin Burns Market Overview at a Glance
4. Skin Burns Market Executive Summary
5. Disease Background and Overview
6. Skin Burns Treatment and Management
7. Skin Burns Epidemiology and Patient Population
8. Patient Journey
9. Skin Burns Emerging Drugs
10. 7MM Skin Burns Market Analysis
11. Skin Burns Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Skin Burns Market Drivers
15. Skin Burns Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Download the sample pages @ Skin Burns Market Outlook
Trending Reports
Adalimumab Biosimilar Market
Skin Burns Market
Artificial Pancreas Device System Market
Dental Equipment Market
Gluten Sensitivity Market
Hypothyroidism Market
Inflammatory Bowel Disease Market
Mayus Kinase Jak Inhibitors Market
Mild Dry Eye Market
Mucopolysaccharidosis Market
Oncolytic Virus Cancer Therapy Market
Pyoderma Gangrenosum Market
Transdermal Drug Delivery Devices Market
Intrathecal Pumps Market
Hedgehog Pathway Inhibitors Market
Yellow Fever Market
Laryngeal Cancer Market
Female Infertility Market
Gender Dysphoria Market
Chronic Brain Damage Market
Spain Healthcare Outlook Market
Malignant Fibrous Histiocytoma Market

Contact Us
Adya Kaul
+1(919)321-6187
info@delveinsight.com
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Skin Burns Market to Witness Growth During the Forecast Period (2023-32), Estimates DelveInsight | Key Companies - Global Blood Therapeutics, GlycoMimetics, Asklepion Pharmaceutical here

News-ID: 3119190 • Views:

More Releases from DelveInsight Business Research LLP

Liver Fibrosis Market Size in the 7MM is projected to grow at a CAGR of 23.9% by 2034, estimates DelveInsight
Liver Fibrosis Market Size in the 7MM is projected to grow at a CAGR of 23.9% by …
DelveInsight's "Liver Fibrosis Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Liver Fibrosis epidemiology, market, and clinical development understanding, Addition to this report provides historical and forecasted epidemiology and market data as well as a detailed analysis on the Liver Fibrosis therapeutics market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. Download DelveInsight's comprehensive report to
Intratumoral Cancer Therapies Market Size in the 7MM is projected to grow at a CAGR of 49.10% by 2034, estimates DelveInsight
Intratumoral Cancer Therapies Market Size in the 7MM is projected to grow at a C …
DelveInsight's "Intratumoral Cancer Therapies Market Insight, Epidemiology and Market Forecast - 2034" report delivers an in-depth analysis of Intratumoral Cancer Therapies epidemiology, market, and clinical development understanding, Addition to this report provides historical and forecasted epidemiology and market data as well as a detailed analysis on the Intratumoral Cancer Therapies therapeutics market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. Download DelveInsight's
Paroxysmal Nocturnal Hemoglobinuria Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight
Paroxysmal Nocturnal Hemoglobinuria Treatment Pipeline Shows Strong Momentum as …
DelveInsight's, "Paroxysmal Nocturnal Haemoglobinuria Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Paroxysmal Nocturnal Haemoglobinuria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Domain | DelveInsight
Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies …
DelveInsight's "Sarcopenia Pipeline Insight 2026" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Sarcopenia pipeline landscape. It covers the Sarcopenia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sarcopenia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Sarcopenia Research. Learn more about

All 5 Releases


More Releases for Burns

Burns Market Massive Growth opportunity Ahead
Introduction Burn injuries remain one of the most severe forms of trauma, affecting millions of people worldwide every year. They can result from heat, chemicals, radiation, or electricity and often require long-term clinical care, reconstructive surgeries, and rehabilitation. Beyond immediate medical intervention, burn injuries create lasting impacts on quality of life, healthcare systems, and economic resources. The global burns market is evolving rapidly with advancements in wound care technologies, skin grafting procedures,
Grow Delivers Robust Loan Qualification Technology to Burns Funding
Grow (https://growfunders.com/), a platform technology company that helps financial services companies and similar entities streamline the loan qualification process, announced today that Burns Funding has become a new client. Burns Funding, a venture debt lender that helps entrepreneurs and investors obtain capital for their existing businesses as well as new ones, needed Grow's Technological platform solution to help it manage the surging demand for its unique product - the Burns Corporate
Bravemark Welcomes Industry Expert Ben Burns as an Advisor
**Miami, Florida - April 17, 2025** - Bravemark, the innovative startup built specifically for brand identity designers, is proud to announce that renowned creative leader and entrepreneur **Ben Burns** has officially joined the company as its first Advisor. With an illustrious career including leadership at *The Futur* alongside Chris Do, creative studio *Blind*, and as founder of the business accelerator *Maker Division*, Burns brings unparalleled expertise to steer Bravemark's strategic vision
Burns Funding Names Rogul Director of Business Development
Burns Funding (www.burnsfunding.com), a venture debt lender that helps entrepreneurs and investors obtain funding for their businesses, has named Daniel "The Dan" Rogul as Director of Business Development. Daniel Rogul, whose past associates credited him with the name of "The Dan" both because of his innate ability to recognize partnership opportunities and close deals, as well as the high standards he has in how he treats people, joins Grace Gillespie, which
Burns Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Burns Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Burns pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Burns Research. Learn more about our innovative pipeline
Steve & Burns: Simplifying Tax Consulting for Small Businesses
Dallas, Texas - Steve & Burns Tax Consulting Services, a leading tax advisory firm, is proud to announce its comprehensive range of tax consulting services [https://steveandburns.com/] specifically tailored to meet the needs of small businesses. As businesses continue to navigate complex tax laws, Steve & Burns offers expert guidance to help companies minimize tax liabilities, optimize tax strategies, and ensure compliance with the latest regulations. Specialized Tax Consulting Services for Small